EMvision Medical Devices Ltd. Statistics
Want to see AU:EMV full AI Analyst Report?
EMvision Medical Devices Ltd. (EMV) Stock Statistics & Valuation Metrics
Total Valuation
EMvision Medical Devices Ltd. has a market cap or net worth of AUD 138.97M. The enterprise value is AUD 127.13M.
- Market Cap
- AUD 138.97M
- Enterprise Value
- AUD 127.13M
Share Statistics
EMvision Medical Devices Ltd. has 92,955,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 92,955,560
- Owned by Insiders
- 0.01%
- Owned by Institutions
- ―
Financial Efficiency
EMvision Medical Devices Ltd.’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -54.64%.
- Return on Equity (ROE)
- -0.53
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -54.64%
- Return on Capital Employed (ROCE)
- -0.89
- Revenue Per Employee
- 0
- Profits Per Employee
- -180.79K
- Employee Count
- 46
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of EMvision Medical Devices Ltd. is -15.61. EMvision Medical Devices Ltd.’s PEG ratio is -1.23.
- PE Ratio
- -15.61
- PS Ratio
- 0.00
- PB Ratio
- 8.40
- Price to FCF
- -20.79
- Price to Operating Cash Flow
- -21.21
- PEG Ratio
- -1.23
Income Statement
In the last 12 months, EMvision Medical Devices Ltd. had revenue of 0 and earned -8.32M in profits. Earnings per share was -0.09.
- Revenue
- 0
- Gross Profit
- -416.90K
- Operating Income
- -16.93M
- Pretax Income
- -13.29M
- Net Income
- -8.32M
- EBITDA
- -16.51M
- Earnings Per Share (EPS)
- -0.09
Cash Flow
In the last 12 months, operating cash flow was -6.25M and capital expenditures -124,224, giving a free cash flow of -6.37M billion.
- Operating Cash Flow
- -6.25M
- Free Cash Flow
- -6.37M
- Free Cash Flow per Share
- -0.07
Dividends & Yields
EMvision Medical Devices Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.81%
- Earnings Yield
- -6.28%
Stock Price Statistics
- Beta
- 0.64
- 52-Week Price Change
- -23.80%
- 50-Day Moving Average
- 1.62
- 200-Day Moving Average
- 1.66
- Relative Strength Index (RSI)
- 43.72
- Average Volume (3m)
- 33.71K
Important Dates
EMvision Medical Devices Ltd. upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 23, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
EMvision Medical Devices Ltd. as a current ratio of 5.53, with Debt / Equity ratio of 21.60%
- Current Ratio
- 5.53
- Quick Ratio
- 5.53
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.83
- Interest Coverage Ratio
- -83.22
Taxes
In the past 12 months, EMvision Medical Devices Ltd. has paid -4.97M in taxes.
- Income Tax
- -4.97M
- Effective Tax Rate
- 0.37
Enterprise Valuation
EMvision Medical Devices Ltd. EV to EBITDA ratio is -7.19, with an EV/FCF ratio of -18.64.
- EV to Sales
- 0.00
- EV to EBITDA
- -7.19
- EV to Free Cash Flow
- -18.64
- EV to Operating Cash Flow
- -19.01
Balance Sheet
EMvision Medical Devices Ltd. has AUD 17.10M in cash and marketable securities with AUD 3.41M in debt, giving a net cash position of AUD 13.70M billion.
- Cash & Marketable Securities
- AUD 17.10M
- Total Debt
- AUD 3.41M
- Net Cash
- AUD 13.70M
- Net Cash Per Share
- AUD 0.15
- Tangible Book Value Per Share
- AUD 0.16
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for EMvision Medical Devices Ltd. is AUD 3.15, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- AUD 3.15
- Price Target Upside
- 121.05% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 20.40%
Scores
- Smart Score
- 4
- AI Score
- 50
